AS

Arvind Singh

Active Director Whole-Time Director DIN 10867785
DIN 10867785 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Arvind Singh

Data last updated:

Arvind Singh is a Whole-Time Director at Saffron India Vet Healthcare Private Limited (since 2024).

DIN 10867785
Primary Designation Whole-Time Director
First Appointment 11 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director11 Dec 20242024Active

Board colleagues of Arvind Singh

NameDINCompanyDesignation
Anuj Tomar10867786Saffron India Vet Healthcare Private LimitedManaging Director
Rajat Kumar Singh10867784Saffron India Vet Healthcare Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Saffron India Vet Healthcare Private Limited
Premium access

Shareholding and investment profile for Arvind Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Singh

Arvind Singh currently holds 1 directorship: Saffron India Vet Healthcare Private Limited (Whole-Time Director, since 11 Dec 2024).

Arvind Singh was first appointed on 11 Dec 2024 as Whole-Time Director at Saffron India Vet Healthcare Private Limited.

The current boards of Arvind Singh's companies include Anuj Tomar (Saffron India Vet Healthcare Private Limited), Rajat Kumar Singh (Saffron India Vet Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available